"{\"uid\": \"article175\", \"entities\": [{\"sentence\": \"The inoculation of a 90-year-old British woman on Tuesday marked the start of the UK's first mass Covid-19 vaccine campaign, and will likely be followed by widespread vaccination globally in the coming months.\", \"from\": 0, \"to\": 209, \"entities\": [{\"begin\": 33, \"end\": 40, \"title\": \"http://dbpedia.org/resource/United_Kingdom\", \"score\": 0.9999979316711249, \"rank\": 2.04313598614331e-06, \"text\": \"British\", \"types\": [\"Q6256\"], \"wikid\": \"http://dbpedia.org/resource/United_Kingdom\", \"dbpedia\": \"http://dbpedia.org/resource/United_Kingdom\"}, {\"begin\": 82, \"end\": 84, \"title\": \"http://dbpedia.org/resource/United_Kingdom\", \"score\": 0.9995538948574835, \"rank\": 0.00029281255929448, \"text\": \"UK\", \"types\": [\"Q6256\"], \"wikid\": \"http://dbpedia.org/resource/United_Kingdom\", \"dbpedia\": \"http://dbpedia.org/resource/United_Kingdom\"}]}, {\"sentence\": \"But while Britain's is certainly the first mass rollout of the Pfizer/BioNTech vaccine, it's not the first widespread use of a coronavirus vaccine per se.\", \"from\": 211, \"to\": 365, \"entities\": []}, {\"sentence\": \"In China, close to a million people have already been given one of the Covid-19 vaccines being developed there, including overseas construction project employees and students, a move that sparked concern among several health experts as the shot has not yet been approved by regulators.\", \"from\": 366, \"to\": 651, \"entities\": []}, {\"sentence\": \"Before Britain granted emergency-authorization to the Pfizer vaccine, a few countries had also used emergency approval to began offering China's Covid-19 shots to health workers.\", \"from\": 652, \"to\": 830, \"entities\": []}, {\"sentence\": \"Advertisement  Currently, four Covid-19 vaccines from three Chinese firms are at an advanced stage: Sinopharm has two vaccines in development; private US-listed biotech firm Sinovac has developed a shot called CoronaVac; and CanSino Biologics also has a candidate.\", \"from\": 832, \"to\": 1096, \"entities\": []}, {\"sentence\": \"Unlike the Pfizer and Moderna vaccines, China's candidates do not require ultra-cold storage, making them especially useful to developing countries.\", \"from\": 1097, \"to\": 1245, \"entities\": []}, {\"sentence\": \"The Sinopharm vaccines have been tested on 60,000 volunteers across Argentina, Bahrain, Egypt, Indonesia, Jordan, Morocco, Peru, Russia, Saudia Arabia, and the United Arab Emirates as part of Phase 3 trials.\", \"from\": 1247, \"to\": 1454, \"entities\": []}, {\"sentence\": \"Sinovac's CoronaVac has been tested in Brazil, Chile, Turkey, and Indonesia, among others.\", \"from\": 1455, \"to\": 1545, \"entities\": []}, {\"sentence\": \"Neither company has released information on efficacy.\", \"from\": 1546, \"to\": 1599, \"entities\": []}, {\"sentence\": \"In contrast, pharmaceutical giants like Pfizer and Moderna made public some findings from their late-stage trial data, while also providing the data to regulators for analysis.\", \"from\": 1601, \"to\": 1777, \"entities\": []}, {\"sentence\": \"Canada followed the UK to give the Pfizer shot emergency approval yesterday, and the US could follow suit this week.\", \"from\": 1778, \"to\": 1894, \"entities\": []}, {\"sentence\": \"The United Arab Emirates said yesterday that data from Phase 3 trials conducted there showed the Sinopharm shot it had used was 86% effective, and confirmed it had registered the vaccine, which is a necessary step for an overseas medicine to be sold in the country.\", \"from\": 1896, \"to\": 2161, \"entities\": []}, {\"sentence\": \"The shot has been in emergency-use for health workers in the Gulf country since September.\", \"from\": 2162, \"to\": 2252, \"entities\": []}, {\"sentence\": \"Last week, China's coronavirus task force said a big announcement on vaccines was coming shortly, which could signal another regulatory development.\", \"from\": 2253, \"to\": 2401, \"entities\": []}, {\"sentence\": \"Advertisement  These are the countries that could use the Chinese vaccines widely starting as soon as next year, judging by their confirmed orders tracked by a Duke University health initiative.\", \"from\": 2403, \"to\": 2597, \"entities\": []}, {\"sentence\": \"One Brazilian state has even set a timeline for when it hopes to use CoronaVac.\", \"from\": 2599, \"to\": 2678, \"entities\": []}, {\"sentence\": \"S\\\\\\\\u00e3o Paulo, home to 46 million people and the country's richest state, said it will start a mass immunization campaign using the drug on Jan. 25, beginning with healthcare professionals, indigenous groups, and people older than 60.\", \"from\": 2679, \"to\": 2915, \"entities\": []}, {\"sentence\": \"S\\\\\\\\u00e3o Paulo's Butantan Institute, the country's top vaccine maker, has been working with Sinovac to carry out the Phase 3 trials on 13,000 volunteers.\", \"from\": 2917, \"to\": 3071, \"entities\": []}, {\"sentence\": \"It said it expects Sinovac to share data from those trials on Dec. 15, and to send them to the country's health regulator.\", \"from\": 3072, \"to\": 3194, \"entities\": []}, {\"sentence\": \"Advertisement  The state plans to vaccinate some 9 million people by the end of March, and send 4 million doses (which will cover 2 million people) to other states, assuming federal regulators sign off.\", \"from\": 3196, \"to\": 3398, \"entities\": []}, {\"sentence\": \"President Jair Bolsonaro has been critical of S\\\\\\\\u00e3o Paulo's work with Sinovac and said he'd rather wait and have the country use the Oxford-AstraZeneca vaccine.\", \"from\": 3399, \"to\": 3563, \"entities\": []}]}"